Life After Breast Cancer - Impact of a Life Coach
Lifecoach
Adjustment to Life After Breast Cancer Treatment: Can a Life-Coach Make a Difference
1 other identifier
interventional
120
1 country
1
Brief Summary
The objectives of our intervention are to
- 1.Ease the transition between cancer treatment and active life, and
- 2.Allow breast cancer survivors to take control of their lives.
- 3.Participants who receive both "group coaching sessions" and "individualized coaching sessions" will report greater post-traumatic growth and quality of life, and less fear of cancer recurrence when compared to the breast cancer survivors who received only the group coaching sessions or usual care.
- 4.Participants who receive only the group coaching sessions will report greater post-traumatic growth and quality of life, and lesser fear of cancer recurrence when compared to the participants who receive usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedAugust 25, 2021
August 1, 2021
12 months
August 12, 2021
August 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Post-traumatic growth (PTG) assessed by the Post-Traumatic Growth Inventory (PTGI)
The PTGI consists of 21 items, the response scale is a 6-point Likert scale asking respondents the degree to which changes occurred in their lives as a result of the crisis, where 0 represented "I did not experience this change" and 5 represented "I experienced this change to a very great degree". The PTGI is composed of 5 subscales, with 5 items measuring the construct New Possibilities, 7 items measuring the construct Relating to Others, 4 items measuring the construct Personal Strength, 3 items measuring the construct Appreciation of Life and 2 items measuring the construct Spiritual Change. The scores are summed to provide an overall measure of post-traumatic growth ranging from 0 - 105 where higher scores indicate more reported growth.
12 months
Secondary Outcomes (2)
Change from baseline Fear of cancer recurrence (FCR) assessed by the Cancer Worry Scale (CWS)
12 months
Change from baseline Quality of life (QoL) assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)-Preference
12 months
Study Arms (3)
Arm 1 - Group and Individual
EXPERIMENTALParticipants in this experimental Arm 1 will receive the 3 group sessions followed by 4 to 5 individual coaching sessions via phone calls that last 60 minutes each.
Arm 2 - Group only
EXPERIMENTALArm 2 will receive only the first 3 Life coach sessions (group session).
Arm 3 - Routine care
NO INTERVENTIONArm 3 will receive routine care by the Breast clinic team for the entire course of the study.
Interventions
Group coaching sessions will be focusing on providing material and tools that guide the participants in the transition from cancer treatment to survivorship. All activities of the group session will be following the "After Cancer Passport" document.
In the individual coaching sessions, the life-coach will provide guidances that help the participants to put tools into actions. All activities are outlined in the After Cancer Passport. Participants will use their Passport for each individual coaching session to outline their objectives and indicators of success. The life coach will also assign activities, such as self-reflection, for the participants to complete between each session.
Eligibility Criteria
You may qualify if:
- have been diagnosed with stage I, II, or III breast cancer;
- are female breast cancer patients over the age of 18;
- have completed anti-cancer treatment via surgery and/or chemotherapy and /or radiation therapy at the McGill University Health Centre Breast Clinic;
- are fluent in written and spoken English or French;
- are alert and oriented and capable of giving informed consent;
- have an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom).
You may not qualify if:
- have a recurrence of breast cancer;
- are diagnosed with a second cancer;
- are diagnosed with stage IV breast cancer due to their worse prognosis; and 4) have an active psychiatric diagnosis that would render adherence to the study problematic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cedar's Breast Clinic, Royal Victoria Hospital
Montreal, Quebec, H3G 1A4, Canada
Related Publications (1)
Tock WL, Maheu C, Blondin S, Lee V, Neuman S, Meterissian S. The Effect of Life Coaching on Post-Traumatic Growth and Well-Being in Breast Cancer Survivors: A Randomized Controlled Trial. Psychooncology. 2025 Oct;34(10):e70295. doi: 10.1002/pon.70295.
PMID: 41068064DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 12, 2021
First Posted
August 25, 2021
Study Start
September 15, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2023
Last Updated
August 25, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- will be submitted to the International Journal of Clinical Trials (IJCT) in November 2022